A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Clinical trial NCT02265705 · COMPLETED

Trial details

NCT number: NCT02265705
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2014-10-01
Primary completion: 2017-05-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.